• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病相关肺动脉高压/慢性血栓栓塞性肺动脉高压中的生物标志物:循环分子和细胞固有标志物

Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.

作者信息

Wang Juan, Zhang Yankun, Liu Huimin, Liu Lingling, Xu Chong, Zhang Jing

机构信息

Department of Respiratory and Critical Care, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Aug 15;20:2869-2883. doi: 10.2147/COPD.S521659. eCollection 2025.

DOI:10.2147/COPD.S521659
PMID:40837110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12364002/
Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic progressive disease of the airways and lungs characterized by persistent respiratory symptoms and airflow limitation. Under hypoxic conditions, endothelial cells and immune cells secrete inflammatory mediators and growth factors, promoting the proliferation of pulmonary vascular smooth muscle cells and fibroblasts, leading to vascular remodeling. Considering the high morbidity and mortality of pulmonary hypertension (PH) in patients with COPD, we investigated the molecular mechanisms underlying vascular remodeling in COPD-related PH. Neurohumoral factor N-terminal brain natriuretic peptide (NT-proBNP), inflammatory mediators, growth factors, and forkhead box M1 (FOXM1) were evaluated as auxiliary diagnostic markers for COPD with PH and chronic cor pulmonale (CCP), aiming to facilitate early PH screening, prevention, and improvement of patient survival and quality of life. Circulating biomarkers (NT-proBNP, inflammatory mediators, growth factors) can be detected via clinical blood sampling, offering non-invasive, convenient diagnostic approaches with high specificity and sensitivity-ideal tools for disease screening. Intracellular molecular marker FOXM1, requiring tissue or enriched cell detection, serves as a histopathological marker and potential target for liquid biopsy, positioning it as a promising future screening tool.

摘要

慢性阻塞性肺疾病(COPD)是一种气道和肺部的慢性进行性疾病,其特征为持续的呼吸道症状和气流受限。在低氧条件下,内皮细胞和免疫细胞分泌炎症介质和生长因子,促进肺血管平滑肌细胞和成纤维细胞的增殖,导致血管重塑。鉴于COPD患者中肺动脉高压(PH)的高发病率和高死亡率,我们研究了COPD相关PH中血管重塑的分子机制。评估了神经体液因子N末端脑钠肽(NT-proBNP)、炎症介质、生长因子和叉头框M1(FOXM1)作为COPD合并PH和慢性肺源性心脏病(CCP)的辅助诊断标志物,旨在促进早期PH筛查、预防并改善患者生存率和生活质量。循环生物标志物(NT-proBNP、炎症介质、生长因子)可通过临床采血检测,提供具有高特异性和敏感性的非侵入性、便捷诊断方法——疾病筛查的理想工具。细胞内分子标志物FOXM1需要进行组织或富集细胞检测,作为组织病理学标志物和液体活检的潜在靶点,使其成为一种有前景的未来筛查工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12364002/0a5af259df16/COPD-20-2869-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12364002/1778a7395d48/COPD-20-2869-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12364002/0a5af259df16/COPD-20-2869-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12364002/1778a7395d48/COPD-20-2869-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12364002/0a5af259df16/COPD-20-2869-g0002.jpg

相似文献

1
Biomarkers in COPD-Associated PH/CCP: Circulating Molecules and Cell-Intrinsic Marker.慢性阻塞性肺疾病相关肺动脉高压/慢性血栓栓塞性肺动脉高压中的生物标志物:循环分子和细胞固有标志物
Int J Chron Obstruct Pulmon Dis. 2025 Aug 15;20:2869-2883. doi: 10.2147/COPD.S521659. eCollection 2025.
2
Predictive Value of Smoking Index Combined with NT-proBNP for Patients with Pulmonary Hypertension Due to Chronic Lung Disease: A Retrospective Study.吸烟指数联合 NT-proBNP 对慢性肺部疾病相关肺动脉高压患者的预测价值:一项回顾性研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 4;19:1233-1245. doi: 10.2147/COPD.S448496. eCollection 2024.
3
B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.B型利钠肽作为儿童肺动脉高压的一个参数:一项系统评价
Eur J Pediatr. 2015 Oct;174(10):1267-75. doi: 10.1007/s00431-015-2619-0. Epub 2015 Aug 23.
4
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension.支持肺动脉高压分类的诊断性微小RNA特征
Circ Genom Precis Med. 2025 Jun;18(3):e004862. doi: 10.1161/CIRCGEN.124.004862. Epub 2025 Apr 18.
5
NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.不同 COPD 患者群体中的 NT-proBNP:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2023 May 10;18:811-825. doi: 10.2147/COPD.S396663. eCollection 2023.
6
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis.氨基末端脑利钠肽前体预测慢性阻塞性肺疾病患者的全因死亡率:系统评价和荟萃分析。
Chron Respir Dis. 2017 May;14(2):117-126. doi: 10.1177/1479972316674393. Epub 2016 Dec 15.
7
Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.终末期慢性阻塞性肺疾病合并与不合并严重肺动脉高压时的特定隔室重塑模式。
J Heart Lung Transplant. 2024 Jul;43(7):1090-1101. doi: 10.1016/j.healun.2024.02.1044. Epub 2024 Feb 19.
8
Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.慢性阻塞性肺疾病相关肺动脉高压中的可溶性转铁蛋白受体-1
Lung. 2025 Jul 14;203(1):79. doi: 10.1007/s00408-025-00833-3.
9
Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.血液生物标志物及其在先天性心脏病相关肺动脉高压中的潜在作用。一项系统综述。
Int J Cardiol. 2014 Jul 1;174(3):618-23. doi: 10.1016/j.ijcard.2014.04.156. Epub 2014 Apr 22.
10
Analysis of Predictive Value of Cellular Inflammatory Factors and T Cell Subsets for Disease Recurrence and Prognosis in Patients with Acute Exacerbations of COPD.细胞炎症因子和 T 细胞亚群对 COPD 急性加重患者疾病复发和预后的预测价值分析。
Int J Chron Obstruct Pulmon Dis. 2024 Nov 1;19:2361-2369. doi: 10.2147/COPD.S490152. eCollection 2024.

本文引用的文献

1
Inhibition of glutaminase 1 reduces M1 macrophage polarization to protect against monocrotaline-induced pulmonary arterial hypertension.抑制谷氨酰胺酶1可减少M1巨噬细胞极化,从而预防野百合碱诱导的肺动脉高压。
Immunol Lett. 2025 Apr;272:106974. doi: 10.1016/j.imlet.2025.106974. Epub 2025 Jan 5.
2
Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1/HIF-1α signaling pathway.Otud6b 通过介导钙蛋白酶 1/HIF-1α 信号通路诱导肺动脉高压。
Cell Mol Life Sci. 2024 Jun 15;81(1):258. doi: 10.1007/s00018-024-05291-3.
3
Cullin 5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF.
Cullin 5通过激活TRAF6/NF-κB/HIF-1α/VEGF加重缺氧性肺动脉高压。
iScience. 2023 Oct 12;26(11):108199. doi: 10.1016/j.isci.2023.108199. eCollection 2023 Nov 17.
4
Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway.LCZ696 通过调节 PI3K/AKT 信号通路对低氧性肺动脉高压大鼠的预防作用。
Pulm Pharmacol Ther. 2023 Oct;82:102229. doi: 10.1016/j.pupt.2023.102229. Epub 2023 Jun 22.
5
NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.不同 COPD 患者群体中的 NT-proBNP:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2023 May 10;18:811-825. doi: 10.2147/COPD.S396663. eCollection 2023.
6
FVC/D identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD.FVC/D 可识别肺动脉高压,并预测 COPD 患者 5 年全因死亡率。
Eur J Med Res. 2023 May 15;28(1):174. doi: 10.1186/s40001-023-01130-6.
7
The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.COPD 人群中肺动脉高压的发病率和患病率:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 10;17:1365-1379. doi: 10.2147/COPD.S359873. eCollection 2022.
8
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.巨噬细胞-NLRP3 激活促进肺动脉高压中的右心衰竭。
Am J Respir Crit Care Med. 2022 Sep 1;206(5):608-624. doi: 10.1164/rccm.202110-2274OC.
9
miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.miR-155-5p 通过靶向 PYGL 调节低氧诱导的肺动脉平滑肌细胞功能。
Bioengineered. 2022 May;13(5):12985-12997. doi: 10.1080/21655979.2022.2079304.
10
Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways.丹参饮颗粒通过STAT3/HIF-1α/VEGF和FAK/AKT信号通路预防缺氧诱导的肺动脉高压。
Front Pharmacol. 2022 Mar 11;13:844400. doi: 10.3389/fphar.2022.844400. eCollection 2022.